Do you live with type 2 diabetes?

Today, millions of people around the world face the daily challenges of diabetes. In 2024 alone, the disease was responsible for 3.4 million deaths - one every nine seconds. Despite advances in medicine, there is still no definitive cure.

But there is a way that can transform the future: clinical research.

What are clinical trials?

Before a new medication is available in pharmacies and clinics, it goes through a series of rigorous steps. This process ensures that it is effective and safe for those in need.

Clinical trials represent the final phases of this journey. This means that the substance under study has already passed numerous previous tests, demonstrating safety. Now, it needs to be evaluated in people, in real-world scenarios, to confirm its ideal dose and its benefit as a treatment.

The entire process is regulated, overseen by medical teams, and monitored closely to ensure the safety of each participant. The results are public, strengthening scientific advancement and allowing for new discoveries.

Also read: "Clinical Trials: What Are the Steps for a New Medication to Reach Pharmacies?"

Why are diabetes trials so important?

Type 2 diabetes is a complex condition, influenced by genetic, environmental, and lifestyle factors. Each person responds differently - and that’s why there is no one-size-fits-all solution.

Participating in a clinical trial is contributing for science to find more effective treatment alternatives that take these differences into account. It is also a way to have access to specialized medical monitoring and new therapeutic possibilities.

Who can participate in Type 2 Diabetes studies

Men and women over 18 years old, with a confirmed diagnosis of type 2 diabetes, can participate.

Who cannot participate at this moment

To ensure the safety of all, certain conditions prevent participation in the studies:

• People with type 1 diabetes

• Anyone using insulin or certain specific diabetes medications (glibenclamide, gliclazide, or glimepiride)

• Anyone continuously using corticosteroids for more than 15 days

• People who have had a heart attack, stroke, or unstable heart failure in the last few months

• Anyone who has had cancer in the last 5 years

• Anyone who has undergone bariatric surgery

• People with abusive use of alcohol or drugs in the last 2 years

• Pregnant women, breastfeeding women, or women trying to get pregnant

• Active smokers

A responsible invitation

Synvia is the largest clinical research company in Latin America, with over 20 years of experience and more than 1,600 studies conducted. We already have more than 150,000 people registered in our programs, always following ethical standards and quality recognized by national and international regulatory agencies.

Participating in a study with us means:

• Free access to the medication under evaluation

• Specialized medical assistance

• Contributing to the advancement of science and the health of millions of people

  
  

How to enroll

If you have type 2 diabetes and would like to know more, please fill out the form available by clicking here. Your participation is voluntary, and you will have all the necessary information before deciding.

This is an invitation to learn, reflect, and, if it makes sense to you, to be part of a global effort to transform diabetes treatment.